IFNA1 and cancer: Among these five ARLs, only AL033527.2 and LINC00460 have been reported as prognostic biomarkers in GC (Tang et al., 2021), TSPOAP1-AS1 has been identified as a prognostic factor in pancreatic cancer (Wang et al., 2022) which may be involved in IFN signaling to influence viral replication (Li et al., 2021a), and CCNT2-AS1 is regarded as a prognostic factor for high-grade renal cell carcinoma (Liu et al., 2019) while LINC01094 has not been reported in any cancer studies.